Melanoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Melanoma stocks.

Melanoma Stocks Recent News

Date Stock Title
May 16 BFRI Biofrontera Inc. (BFRI) Q1 2024 Earnings Call Transcript
May 16 AIM AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Call Transcript
May 16 IOVA 4 Small-Cap Value Stocks That Could Go Parabolic
May 16 AIM AIM ImmunoTech GAAP EPS of -$0.12
May 16 AIM AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 16 SSKN Strata Skin Sciences Inc (SSKN) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
May 16 SSKN STRATA Skin Sciences, Inc. (SSKN) Q1 2024 Earnings Call Transcript
May 15 BFRI Biofrontera GAAP EPS of -$2.88, revenue of $7.9M
May 15 BFRI Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
May 15 SSKN STRATA Skin Sciences GAAP EPS of -$0.10 misses by $0.03, revenue of $6.75M misses by $0.16M
May 15 SSKN STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update
May 15 AIM AIM ImmunoTech Q1 2024 Earnings Preview
May 15 PDSB PDS Biotechnology GAAP EPS of -$0.30 beats by $0.06
May 15 PDSB PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
May 14 SSKN STRATA Skin Sciences Q1 2024 Earnings Preview
May 14 TSBX Turnstone Biologics reports Q1 results
May 14 SSKN STRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices as of March 31, 2024
May 13 TSBX Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
May 13 SSKN STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conference
May 13 IOVA Iovance Biotherapeutics' Amtagvi: Innovative Therapy, Financial Strain (Rating Downgrade)
Melanoma

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.The primary cause of melanoma is ultraviolet light (UV) exposure in those with low levels of skin pigment. The UV light may be from either the sun or from other sources, such as tanning devices. About 25% develop from moles. Those with many moles, a history of affected family members, and who have poor immune function are at greater risk. A number of rare genetic defects such as xeroderma pigmentosum also increase risk. Diagnosis is by biopsy and analysis of any skin lesion that has signs of being potentially cancerous.Using sunscreen and avoiding UV light may prevent melanoma. Treatment is typically removal by surgery. In those with slightly larger cancers, nearby lymph nodes may be tested for spread. Most people are cured if spread has not occurred. For those in whom melanoma has spread, immunotherapy, biologic therapy, radiation therapy, or chemotherapy may improve survival. With treatment the five-year survival rates in the United States is 98% among those with localized disease and 17% among those in whom spread has occurred. The likelihood that it will come back or spread depends how thick the melanoma is, how fast the cells are dividing, and whether or not the overlying skin has broken down.Melanoma is the most dangerous type of skin cancer. Globally, in 2012, it newly occurred in 232,000 people. In 2015 there were 3.1 million with active disease which resulted in 59,800 deaths. Australia and New Zealand have the highest rates of melanoma in the world. There are also high rates in Northern Europe and North America, while it is less common in Asia, Africa, and Latin America. Melanoma is more common in men than women. Melanoma has become more common since the 1960s in areas which are mostly populated with white people.

Browse All Tags